[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100142838":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":11,"locations":11,"responsibleParty":25,"collaborators":11,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":31,"acronym":11,"eligibilityCriteria":32,"healthyVolunteers":33,"sex":34,"minAge":35,"maxAge":36,"enrollmentInfo":37,"targetDuration":11,"studyType":40,"phases":41,"briefSummary":43,"conditions":44,"keywords":46,"overallStatus":51,"whyStopped":11,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":58,"locationsCount":11},{"fullName":5,"class":6},"AbbVie","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"1","EXPERIMENTAL",null,[13],"Drug: Testosterone Gel 1.62%",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DRUG","Testosterone Gel 1.62%","5 grams",[9],[21],{"name":22,"affiliation":23,"role":24},"Michael Miller, PharmD","Abbott","STUDY_DIRECTOR",{"type":26,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100142838","phase-1-an-open-label-study-of-serum-testosterone-levels-in-non-dosed-females-after-secondary-exposure-to-testosterone-gel-162-applied-to-the-upper-arms-and-shoulders-and-use-of-a-t-shirt-barrier-100142838",false,"NCT01130298","An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier","Inclusion Criteria\n\n* BMI between 20-35 kg\u002Fm\\^2 inclusive.\n\nExclusion Criteria\n\n* Males: history, current or suspected prostate or breast cancer.\n* Females: pregnant or lactating.",true,"ALL","18 Years","80 Years",{"count":38,"type":39},24,"ACTUAL","INTERVENTIONAL",[42],"PHASE1","Single-center, single dose, open-label study in healthy male and female volunteers to further characterize the transfer potential of Testosterone Gel 1.62% formulation.",[45],"Healthy",[47,48,49,50],"testosterone,","Pharmacokinetics","replacement,","therapy","COMPLETED","2017-12-05",{"date":54,"type":39},"2017-12-07",{"date":56,"type":11},"2010-05",{"date":56,"type":39},{"name":5,"class":6}]